Back to Journal

SM Journal of Nephrology and Kidney Diseases

Robot-Assisted Laparoscopic Bladder Neck Reconstruction with Retzius-Sparing Approach for the Treatment of 3 Cases of Refractory Bladder Neck Contracture

[ ISSN : 2576-5450 ]

Abstract Abstract Keywords Citation INTRODUCTION RESULTS DISCUSSION CONCLUSION REFERENCES
Details

Received: 01-Dec-2024

Accepted: 13-May-2025

Published: 03-Jun-2025

Yongsen Wu¹,², Dan Lu¹,², Jiannan Liu², Xiaoxiao Wang², Ying Xiang², and Wei Xiong2*

1 School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, China

2 Department of Urology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, China

Corresponding Author:

Wei Xiong, Department of Urology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, China.

Keywords

Bladder Neck Contracture; Retzius-Sparing; Robotic Surgery; Urethral Reconstruction Surgery.

Abstract

We present the preliminary outcomes of robotic-assisted surgical treatment for bladder neck contracture (BNC), using the innovative Robot-Assisted Laparoscopic Retzius-Sparing Bladder Neck Reconstruction (RAL-RSBNR), technique. Between August and October 2024, three adult male patients underwent RAL-RSBNR at our institution. All patients developed BNC following transurethral resection of the prostate (TURP), for benign prostatic hyperplasia (BPH), and had previously undergone multiple urethral dilation procedures. One patient had experienced recurrent TURP interventions. All RAL-RSBNR procedures were performed using a transperitoneal six-port approach with a four-arm robotic system. No significant intraoperative or postoperative complications were observed. At two weeks postoperatively, all three patients successfully had their catheters removed without notable voiding difficulties. Current literature identifies the RAYV technique as the predominant robotic-assisted approach for treating BNC. In contrast, our novel RAL-RSBNR technique addresses BNC at its root, effectively preventing recurrence often associated with endoscopic surgeries, while maintaining a favorable safety profile with no major complications. These preliminary results indicate that RAL-RSBNR holds significant potential as a promising option for BNC treatment. Nevertheless, given the short study period, further clinical data and extended follow-up are required to thoroughly evaluate the long-term outcomes and efficacy of RALRSBNR.

Abstract

We present the preliminary outcomes of robotic-assisted surgical treatment for bladder neck contracture (BNC), using the innovative Robot-Assisted Laparoscopic Retzius-Sparing Bladder Neck Reconstruction (RAL-RSBNR), technique. Between August and October 2024, three adult male patients underwent RAL-RSBNR at our institution. All patients developed BNC following transurethral resection of the prostate (TURP), for benign prostatic hyperplasia (BPH), and had previously undergone multiple urethral dilation procedures. One patient had experienced recurrent TURP interventions. All RAL-RSBNR procedures were performed using a transperitoneal six-port approach with a four-arm robotic system. RSBNR. No significant intraoperative or postoperative complications were observed. At two weeks postoperatively, all three patients successfully had their catheters removed without notable voiding difficulties. Current literature identifies the RAYV technique as the predominant robotic-assisted approach for treating BNC. In contrast, our novel RAL-RSBNR technique addresses BNC at its root, effectively preventing recurrence often associated with endoscopic surgeries, while maintaining a favorable safety profile with no major complications. These preliminary results indicate that RAL-RSBNR holds significant potential as a promising option for BNC treatment. Nevertheless, given the short study period, further clinical data and extended follow-up are required to thoroughly evaluate the long-term outcomes and efficacy of RAL-RSBNR

Keywords

Bladder Neck Contracture; Retzius-Sparing; Robotic Surgery; Urethral Reconstruction Surgery.

Citation

Wu Y, Lu D, Liu J, Wang X, Xiong W, et.al, (2025) Robot-Assisted Laparoscopic Bladder Neck Reconstruction with Retzius-Sparing Approach for the Treatment of 3 Cases of Refractory Bladder Neck Contracture. J Nephrol Kidney Dis 6(1): 5.

INTRODUCTION

Bladder neck contracture (BNC) is a common postoperative complication in urological surgery, particularly after prostate procedures. Its primary symptoms include difficulty urinating, urinary flow obstruction, and even complete urinary retention, which significantly impact patients’ quality of life. Traditional treatment options such as urethral dilation, endoscopic incision, and laser therapy are widely used; however, recurrence of the contracture occurs in approximately half of the case [1]. With the continuous advancements in robotic surgical technology, robot-assisted surgery has gained increasing popularity in the treatment of BNC. Bladder neck Y-V plasty involves creating a Y-shaped incision at the bladder neck and suturing it into a V shape, effectively enlarging the bladder outlet, alleviating urinary obstruction, and reducing the risk of recurrence. However, this technique is associated with a potential risk of postoperative urinary incontinence [2]. The T-plasty approach, on the other hand, involves exposing the bladder neck, excising scar tissue, and performing a T-shaped incision on the anterior bladder wall, which helps to lower the incidence of postoperative urinary incontinence [3]. Meanwhile, urethral repair and reconstruction techniques utilizing the Retzius-sparing approach offer a new treatment option for patients with bladder neck contracture.

PATIENTS AND METHODS

From July to October 2024, three patients with refractory bladder neck contracture (BNC) underwent robot-assisted laparoscopic Retzius sparing bladder neck reconstruction (RAL-RSBNR), at our institution. All cases of BNC occurred following transurethral plasmakinetic resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). Of these, two patients showed no improvement despite multiple endoscopic resection attempts. Patient histories, surgical details, postoperative courses, and follow up data were retrospectively collected and analyzed using medical records and patient questionnaires. The questionnaire included the International Prostate Symptom Score (IPSS), which aligns with the American Urological Association Symptom Index (AUA-SI). All patients were fully informed of the procedure and provided written consent. Postoperative complications were documented and classified according to the Clavien-Dindo grading system.

SURGICAL TECHNIQUE

All procedures were performed by an experienced robotic urologist using the da Vinci surgical robotic system. A transperitoneal six-port approach was utilized, with patients positioned in a lithotomy setup and a 30° Trendelenburg tilt. The surgery commenced with cystoscopy to assess the anatomical relationship between the bladder neck and the urethral sphincter. The robotic system was then employed to access the bladder through a posterior approach, dissecting along the pelvic wall, Denonvilliers’ fascia, and the lateral walls of the prostate down to its apex. At the bladder neck, a transverse incision was made on the posterior bladder neck at the junction of the prostate and bladder. After opening the posterior bladder neck, traction was applied to expose the anterior bladder neck, which was subsequently incised. Bladder neck reconstruction involved creating a fish-mouth-shaped configuration. A double-layer continuous anastomosis was performed using 3-0 absorbable barbed sutures (5/8 curved needle) to seamlessly connect the urethra to the bladder neck opening.

RESULTS

The patient characteristics and perioperative outcomes are summarized in Table 1. No major intraoperative or postoperative complications occurred in any of the patients. The follow-up period ranged from 1 to 4 months. During this time, all three patients successfully had their catheters removed between 14 and 15 days postoperatively, with no cases of urinary incontinence. All patients regained satisfactory voiding function. The median International Prostate Symptom Score (IPSS) during follow-up was 4.6, indicating that all patients experienced only mild urinary symptoms. 

Table 1: Characteristics, Perioperative Outcomes, Postoperative Complications, and Follow-up Results of Patients Undergoing Robot-Assisted Laparoscopic Retzius-Sparing Bladder Neck Reconstruction

Patient

1

2

3

Age(years)

71

78

60

BMI(kg/m3 )

22.6

18.3

22.5

Age-adjusted CCl

3

3

2

Probale BNC cause

TURP

TURP

TURP

 

Preceding procedures

 

2×Bladder Neck Incision

 

2×Bladder Neck Incision, 2×Transurethral Dilation

 

-

Surgical procedure

RAL-RSBNR

RAL-RSBNR

RAL-RSBNR

Surgical time(min)

81

73

108

Blood loss

150

200

200

Removal of drainage(days)

3

8

3

 

Removal of transurethral catheter(days)

 

14

 

15

 

15

Hospital stay(days)

7

11

11

90-day's postoperative complications (Clavien-Dindo)

 

-

 

-

 

-

BNC Recurrence

No

No

No

IPSS

3

7

4

Did your voiding function improve after

RAL-RSBNR?

 

Yes

 

Yes

 

Yes

Abbreviations

BMI: Body Mass Index, BNC: Bladder Neck Contracture, CCI: Charlson Comorbidity Index, IPSS: International Prostate Symptom Score,RAL- RSBNR:Robot-Assisted Laparoscopic Retzius-Sparing Bladder Neck Reconstruction

Figure 1: Transperitoneal Six-Port Approach (Four-Arm Robotic Setup).The patient is positioned in a Trendelenburg lithotomy position. RP: Robotic Ports, CP: Camera Port, AP: Assistant Port.

Figure 2: Intraoperative cystoscopy was performed to examine the condition of the bladder neck.

Figure 3: Radical prostatectomy via a transvesical posterior approach.(a) Resection of the prostatic base.(b) Resection of the prostatic apex

Figure 4: Reconstruction of the bladder neck using a 3-0 barbed absorbable suture with double needles.

 

DISCUSSION

Transurethral resection of the prostate (TURP) is one of the earliest and most widely used minimally invasive procedures for treating benign prostatic hyperplasia (BPH). However, bladder neck contracture (BNC) occurs in approximately 2.2% to 9.8% of patients following TURP, with some studies suggesting an incidence as high as 15.8%. This complication significantly reduces postoperative quality of life [2-6]. The primary treatment for BNC is surgical intervention, where complete excision of scar tissue and full incision of the contracture ring are essential for success. Despite this, recurrence rates remain high. Transurethral bladder neck incision is the standard treatment for BPH related BNC. However, Kranz [7]reported that while the success rate for the initial bladder neck incision is 65%, it drops to just 25% for patients undergoing three or more repeat procedures.

For refractory BNC, open reconstructive surgeries such as abdominoperineal bladder neck resection with anastomosis or bladder neck Y-V plasty are considered effective options. Nevertheless, these open surgeries require extensive midline abdominal incisions to expose the surgical field, posing significant risks to pelvic floor function. Robotic-assisted laparoscopic approaches, by contrast, offer greater precision in anatomical localization and bladder neck dissection, reducing trauma and complications compared to open surgery. Currently, minimally invasive robotic surgeries for refractory BNC typically employ Y-V plasty or modified T-plasty techniques. However, recurrence rates for these methods remain at 20% to 30%. Additionally, the disruption of the Retzius space during these procedures often compromises postoperative urinary continence [8]. In our case series, the RAL-RSBNR technique proved feasible and demonstrated potential as an effective treatment for BNC. The minimally invasive nature of this approach resulted in no major intraoperative or postoperative complications. Crucially, the preservation of the Retzius space minimized disruption to bladder neck support structures, safeguarding urinary continence and reducing the risk of pelvic nerve damage. This preservation also significantly decreased the likelihood of sexual dysfunction and urinary incontinence [9]. Among the three patients in our study, no BNC recurrence was observed within three months postoperatively. While the absence of cystoscopic evaluation prevents us from ruling out subclinical recurrence entirely, the median IPSS score of 4 suggests favorable outcomes. All patients expressed willingness to undergo RAL-RSBNR again if necessary. In summary, our preliminary follow-up results indicate that RAL RSBNR is as effective as well-established open surgeries for the treatment of BNC. Furthermore, it may offer advantages over the current mainstream RAYV approach in specific aspects, particularly in reducing complications and preserving pelvic function.

CONCLUSION

Reports on the application of RAL-RSBNR for treating refractory bladder neck contracture (BNC) remain scarce. However, robot-assisted laparoscopic Retzius-sparing urethral repair and reconstruction has shown promising efficacy, particularly in managing recurrent and treatment-resistant cases. This technique significantly reduces the risk of postoperative complications, preserves the Retzius space to minimize urinary incontinence, and facilitates the recovery of urinary continence. The robotic surgical system’s high-definition 3D visualization and stable mechanical arms improve the precision of fibrotic tissue excision and urethral suturing while minimizing disruption to surrounding tissues. This leads to faster postoperative recovery, shorter hospital stays, and an overall enhancement in quality of life for patients. In our case series, RAL-RSBNR was successfully performed on all patients without major intraoperative or postoperative complications. However, given the limited study duration, further clinical data and extended follow-up are required to validate the long-term efficacy and safety of RAL-RSBNR. As robotic surgical technology continues to evolve and become more accessible, this approach has the potential to establish itself as the standard treatment for bladder neck contracture in the future.

REFERENCES

  1. Ramirez D, Simhan J, Hudak SJ, Morey AF. Standardized approach for the treatment of refractory bladder neck contractures. Urol Clin North Am. 2013; 40: 371-380.
  2. Kurtzman JT, Blum R, Brandes SB. Lower Urinary Tract Stenosis Following Surgery for Benign Prostatic Hyperplasia. Curr Urol Rep. 2021; 22: 55.
  3. Reiss CP, Rosenbaum CM, Becker A, Schriefer P, Ludwig TA, Engel O, et al. The T-plasty: a modified YV-plasty for highly recurrent bladder neck contracture after transurethral surgery for benign hyperplasia of the prostate: clinical outcome and patient satisfaction. World J Urol. 2016; 34: 1437-1442.
  4. Sekar H, Palaniyandi V, Krishnamoorthy S, Kumaresan N. Post- transurethral resection of prostate urethral strictures: Are they often underreported? A single-center retrospective observational cohort study. Urol Ann. 2021; 13: 329-335.
  5. Li J, Ruan J, Hong S. Analysis and prevention of urethral stricture after transurethral resection of the prostate. Clinical Medicine. 2007; 27: 29-30
  6. Castellani D, Wroclawski ML, Pirola GM, Gauhar V, Rubilotta E, Chan VW, et al. Bladder neck stenosis after transurethral prostate surgery: a systematic review and meta-analysis. World J Urol. 2021; 39: 4073-4083.
  7. Kranz J, Reiss PC, Salomon G, Steffens J, Fisch M, Rosenbaum CM. Differences in Recurrence Rate and De Novo Incontinence after Endoscopic Treatment of Vesicourethral Stenosis and Bladder Neck Stenosis. Front Surg. 2017; 4: 44.
  8. Zhang TR, Alford A, Zhao LC. Summarizing the evidence for robotic- assisted bladder neck reconstruction: Systematic review of patency and incontinence outcomes. Asian J Urol. 2024; 11: 341-347.
  9. Lei PENG, Jinze LI, Dandan TANG, Tangqiang WEL, Yunxiang LI. Safety and efficacy of Retzius-sparing robot-assisted laparoscopic radical prostatectomy: meta-analysis. J Clin Urol. 2020; 35: 516-522.

Citation

Wu Y, Lu D, Liu J, Wang X, Xiong W, et.al, (2025) Robot-Assisted Laparoscopic Bladder Neck Reconstruction with Retzius-Sparing Approach for the Treatment of 3 Cases of Refractory Bladder Neck Contracture. J Nephrol Kidney Dis 6(1): 5.

Other Articles

Article Image 1

High-Dose Statin Associated with Rhabdomyolysis, Acute Kidney Injury, Cholestatic Liver Injury, and Thrombocytopenia

Introduction: Statins are the drugs of choice to reduce cholesterol and the incidence of cardiovascular events. Although rare, the side effects of these drugs may be severe (especially when given in the high doses recommended by the cardiologists), including: muscle damage, renal and liver injury and compromised function, and polyneuropathy.

Case Report: We report a case of statin-induced rhabdomyolysis, acute kidney and liver failure and thrombocytopenia that developed in a 76-year-old man, who was referred to our department because of severe generalized myalgia and muscle weakness, extreme fatigue, loss of appetite, dark brown urine. Following an acute myocardial infarction 8 months previously he was put on atorvastatin 80 mg once daily. Laboratory evaluation at presentation revealed much increased levels of muscle enzymes, aminotransferases, total and conjugated bilirubin, and nitrogenous waste products, and low platelets. A diagnosis of acute renal and liver failure secondary to the long-term intensive statin therapy was made. Atorvastatin was discontinued and forced alkaline diuresis was started. After five days of oliguria and slight but persistent increase in creatinine levels dialysis was initiated, but discontinued after 4 sessions, once urine output increased. At discharge the patient’s serum creatine kinase level was in the normal range, creatinine was significantly decreased the thrombocyte count was better, aminotransferase were much lower but not completely normalized, but the bilirubin remained at the same level. The patient was discharged and instructed to avoid any potentially nephrotoxic and hepatotoxic drugs until next outpatient evaluation.

Conclusions: Our case report is meant to raise concerns about prescribing high dose statins. Unfortunately the prescribing cardiologists may be insufficiently aware of the potential for severe adverse effects as these come to the attention of clinicians from different specialities, especially nephrologists.

Dorin Dragos1,2, Diana Pruteanu2 and Rodica Constantin2


Article Image 1

Infections in Pediatric Dialysis Patients in Mubarak Al-Kabeer Hospital, Kuwait: 10 Year

Objective: As the incidence of End Stage Renal Disease (ESRD) worldwide has increased, so has the need for performing Hemodialysis (HD) and Peritoneal Dialysis (PD). We sought to identify risk factors and measure the rate of infections in pediatric patients undergoing dialysis.

Design: A retrospective study

Setting: Single pediatric dialysis center in Kuwait from July 2003-July 2013

Subjects: Pediatric patients undergoing PD or HD

Interventions: Follow up of risk factors and rate of infections incidents

Main outcome measures: Risk factors, incidence rate of infections and microbiological profile of organisms causing dialysis-related infections were determined in HD or PD patients.

Results: A total of 91 patients underwent HD and 63 patients underwent PD. The episodes of infection were documented in 13 patients in each of the two groups. Our rates of infection were found to be one peritonitis episode per 20 patient-months in PD group and 0.41 infection episodes per patient-year in HD group. The commonest organisms isolated in PD-related infections were Pseudomonas aeruginosa and CoagulaseNegative Staphylococci (CNST) whereas in HD-related infections CNST was the leading organism. Among the risk factors in both groups, personal hygiene was the most significant with a P-value of

Conclusion: Our infection rates were consistent with international reports and consistent with others in proving poor personal hygiene as a significant risk factor for infection in patients undergoing renal dialysis.

Wadha Alfouzan¹˒²*, Faisal Alkandari³, Ayman Yosri³, Fawaz Azizieh⁴, Haya Al Tawalah⁵ and Dhar R²


Article Image 1

Evaluating the Kidney Stones; are the Volume and Size Equal in One or Two Dimensions? Accustomed Inaccuracy

Urinary lithiasis is a common disease, prevalence rates vary from 1% to 20%, according to gender, dietary, ethnic, the geographical, and genetic factors.

Musab Ilgi*, Kaya Horasanli and Sinan Levent Kirecci


Article Image 1

Biochemical and Histological Evaluation of Kidney Function in Rats after a Single Administration of Cyclophosphamide and Ifosfamide

Background: Cyclophosphamide (CP) and Ifosfamide (IF) are widely used cytotoxic agents. Both CP and IF exert some characteristic adverse drug reactions including kidney damage taking various clinical forms, depending on the applied dose or administration route. The aim of our study was to estimate kidney function using selected, classical biochemical parameters as well as analyzing the urinary concentration and excretion of a modern “kidney troponin” - neutrophil gelatinase-associated lipocalin-1 (NGAL-1) in rats after administration of a single CP or IF dose.

Methods: 30 rats were divided into three groups (n=10 each; half males and females): group 1 - control (rats receiving i.p. saline solution); groups 2 and 3 – rats intraperitoneally treated with a single CP or IF dose of 150 mg/kg b.w., respectively. Following saline/CP/IF administration, animals were housed in single metabolic cages, to assess 24-hour diuresis and to obtain urinary samples for further laboratory assays. Finally, blood samples were collected and rats were sacrificed to perform autopsy with cystectomy and nephrectomy with subsequent histopathological analysis. Standard parameters of kidney function were assayed either in blood or in urine with an additional assessment of the urine NGAL-1 level.

Results: Single administration of both CP and IF resulted in decreased pH of urine and proteinuria accompanied by an increased 24-hour urinary NGAL-1 excretion. Moreover, CP-treated rats demonstrated polyuria. Concentrations and 24-hour excretion of most classical, low-weight parameters were not different in both CP- and IF-treated rats compared to values observed in control animals.

The histopathological analysis in CP/IF treated animals revealed presence of cystic inflammatory lesions and a normal kidney structure, with the exception of a mild to moderate congestive hyperemia.

Conclusion: A single administration of CP and IF caused a functional kidney tubulopathy in study rats manifested by marked proteinuria with increased 24-hour NGAL-1 urinary excretion.

Łukasz Dobrek*, Agnieszka Baranowska, Beata Skowron and Piotr Thor


Article Image 1

Serum Glycoprotein Chondrex (YKL-40) and High Sensitivity C- Reactive Protein (hscrp) in Type 2 Diabetic Patients in Relation to Cardiovascular Complications

In Type 2 diabetes, C-Reactive Protein (CRP) as an inflammatory marker may be elevated. The glycoprotein Chondrex or YKL-40 is over expressed in many inflammatory conditions. The aim is to study serum hsCRP and YKL-40 in Type 2 diabetic patients in relation to cardiovascular complications.

Methods: Eighty subjects were divided into 3 groups: GROUP 1:16 apparently healthy controls, GROUP 2:16 patients suffering from Type 2 DM without cardiovascular complications and GROUP 3: 48 patients suffering from Type 2 DM with cardiovascular complications. Subjects with acute or chronic inflammation, autoimmune disease or malignancy were excluded. Electrocardiography, Carotid Intima Thikness, Fundus Examination, laboratory investigations: (Complete urine analysis, urinary albumin, Creatinine and calculation of urinary albumin to creatinine ratio, fasting and postprandial glucose, glycated hemoglobin, Creatinine and uric acid, lipid profile, glomerular filtration rate, CRP and YKL-40) were done to all subjects.

Results: High sensitivity CRP levels were significantly elevated in the diabetic group with cardiovascular complications when compared to the diabetic group without cardiovascular complications (p=0.024). YKL-40 was significantly higher in patients with type 2 diabetes mellitus than controls (p=0.017) and cardiovascular complications (p<0.001) contributed to its greater elevation.YKL-40 was positively correlated with triglycerides, systolic and mean blood pressure in the group of diabetic patients without cardiovascular complications and with duration of diabetes and urinary albumin to creatinine ratio in the group with cardiovascular complications. By drawing receiver operating characteristic (ROC) curve between diabetic patients without and with cardiovascular complications the AUC for hsCRP was (0.676, p=0.036) and for YKL-40 was (0.743, p=0.004). By studying the diagnostic performance, YKL-40 had a better specificity and positive predictive value than hsCRP.

Conclusion: YKL-40 has a better specificity and positive predictive value than hsCRP in discriminating between diabetic patients with cardiovascular complications from those without cardiovascular complications.

El-Attar HA¹*, El-Deeb MM¹ and El-Ghlied LA²


Article Image 1

Is There An Association Between Angiotensin II Type 1 Receptor A1166C Gene Polymorphism and Renal Scarring Susceptibility?

Relationship between Angiotensin II Type 1 Receptor (AT1R) A1166C gene polymorphism and renal scarring risk is still controversial. This meta-analysis was performed to evaluate the association of AT1R A1166C gene polymorphism and renal scarring risk susceptibility. A predefined literature search and selection of eligible relevant studies were performed to collect data from electronic databases of PubMed, Embase and Cochrane Library. Three literatures were identified and included for the analysis of the relationship between AT1R A1166C gene polymorphism and renal scarring risk. We found that AT1R A1166C gene polymorphism was not associated with renal scarring susceptibility using the comparison of patients with scarring vs patients without scarring (C: OR=1.33, 95%CI: 0.83-2.13, P=0.23; CC: OR=1.71, 95%CI: 0.22-13.56, P=0.61; AA: OR=0.69, 95%CI: 0.39-1.21, P=0.20). Furthermore, AT1R A1166C gene polymorphism was also not associated with renal scarring risk using the comparison of patients with scarring vs healthy control. In conclusion, AT1R A1166C gene polymorphism was not associated with renal scarring risk susceptibility. However, more studies should be performed in the future.

Tianbiao Zhou*#, Weiji Xie#, Zhijun Lin# and Zhensheng Yang


Article Image 1

Evaluation of Antidiabetic Plants used by Tribes of Telangana State on Diabetic Complications like Neuropathy, Nephropathy and Cardiomyopathy in Rats

Background: India is “diabetes capital of the world”. Diabetes Atlas 2006 published by International Diabetes Federation, India currently around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are taken. Over the past 30 yr, the status of diabetes has changed from being considered as a mild disorder to major causes of morbidity and mortality.

Methods: Rats treated with Alloxan (150 mg/kg) i.p. results diabetic rats given ethanol extract of Senna auriculata leaf, Syzygium cumini (L.) Skeels seeds and Syzygium cumini (L.) Skeels seeds (150 mg/kg) p.o., respectively for 42 days. Biochemical parameters of diabetic neuropathy, nephropathy and cardiomyopathy and histopathology of sciatic nerve, kidney and heart was done at the end of study.

Results: In Diabetic Group found Blood Glucose Level (BGL) (84.42±6.384 to 369.36±7.784mg/dl); Muscle Grip Strength (MGS) (59.32±1.052 to 13.52±0.883seconds); Thermal Pain Response (TPR) (5.55±0.621 to 13.67±1.164seconds). blood protein (7.48±0.051 to 25.18±0.046mg/dl); urine protein (0.692±0.061 to 2.68±0.056mg/dl); blood albumin (1.94±0.043 to 0.248±0.007mg/dl); urine albumin (0.082±0.009 to 2.68±0.056mg/dl); blood myoglobin (0.042±0.00274 to 0.056±0.00207ng/dl); urine myoglobin (0.0048±0.00142 to 0.0098±0.00107mg/dl); Blood Urea Nitrogen (BUN) (23.04±1.093 to 124.81±1.238 mg/dl); Serum Creatinine (84.06±6.723 to 218.56±7.586 (µMol/dl). Etholic extract of Senna auriculata leaf, Phyllanthus emblica.L. fruits and Syzygium cumini (L.) Skeels seeds & combination treated groups found BGL124.42±7.042, 112.07±6.942, 126.25±7.051 & 98.83±6.932mg/dl; MGS 49.06±0.962, 52.05±1.247, 54.06±1.268 & 56.79±1.125 seconds; TPR 6.54±0.841, 7.38±0.802, 6.45±1.062 & 6.14±0.837 seconds; blood protein 7.98±0.039, 8.02±0.053, 8.06±0.039 & 7.48±0.045mg/dl; urine protein 1.22±0.058, 0.94±0.049, 0.96±0.056 & 0.82±0.062mg/dl; blood albumin 1.64±0.033, 1.82±0.036, 1.87±0.044 & 1.96±0.039mg/dl; urine albumin 0.122±0.008, 0.098±0.007, 0.132±0.009 & 0.108±0.011mg/dl; blood myoglobin 0.045±0.00189, 0.036±0.00177, 0.041±0.00223 & 0.043±0.00175ng/dl; urine myoglobin 0.0042±0.00129, 0.0052±0.00119, 0.0064±0.00126 & 0.0036±0.00125mg/dl; BUN 35.81±1.186, 36.06±1.123, 34.53±1.177 & 29.03±1.229mg/dl; Serum Creatinine 98.42±5.526, 99.73±6.064, 101.97±6.052 & 94.83±6.678µMol/dl.

Conclusion: Ethanol extract of Senna auriculata leaf, Phyllanthus emblica L. fruit and Syzygium cumini (L.) Skeels seeds (150mg/kg) and its combination normalizes biochemical parameters & Morphological changes in sciatic nerve, myocardium & kidney and improvement of the general behavioral parameters. Combination was found to be more effective in these diabetic complications.

Syed Ahmed Hussain and Ashish Kumar Sharma*


Article Image 1

Uric Acid, Metabolic Risk Factors, and Chronic Kidney Disease: Clinical Investigation in a Female Elderly Occupational Population in Taipei, Taiwan

Purpose: To explore the prevalence and associated factors for Chronic Kidney Disease (CKD) among female elderly fishing and agricultural population in Taipei, Taiwan.

Methods: Females (n=1,606) aged 65 years and over voluntarily admitted to a teaching hospital for a physical check-up were collected in 2010.

Results: The prevalence of CKD was 8.2%. Age, hyperuricemia, and hyperglycemia were statistical significantly related to CKD. The sensitivity and specificity of serum uric acid and fasting blood glucose concentration as a marker of CKD were estimated 76.5%, 70.9% and 51.5%, 53.5%, respectively.

Conclusion: Hyperuricemia and hyperglycemia independently affect the prevalent CKD in this sub-population.

Ya-Ting Liang¹, Hsi-Che Shen²˒³˒⁴, Yi-Chun Hu²˒³˒⁵, Yu-Fen Chen⁶˒⁷˒⁸ and Tao-Hsin Tung⁹˒¹⁰˒¹¹*


Article Image 1

Pseudohypercreatininemia after Sustanon Injection

The drugs used in the treatment of certain diseases may give impression of impaired renal function. These drugs cause a false high serum creatinine level. Laboratory findings other than serum creatinine and hypertriglyceridemia were normal. We presented a 28-year-old male with a high serum creatinine level, who was referred for consideration of urgent renal replacement therapy. The results of the investigations revealed that the result was the falsely-elevated serum creatinine due to the sustenance injection.

Can Hüzmeli¹, Mustafa Sağlam¹, Bariş Döner¹, Serkan Çağlar² and Özkan Güngör³


Article Image 1

Peripheral Arterial Disease Holding Central Stage in Chronic Kidney Disease (Kdoqi Stage 3-5): Prevalence and Related Risk Factors - Experience from Kashmir Valley Tertiary Care Centre

Patients with CKD are highly predisposed for developing accelerated atherosclerosis. These patients have non-traditional risk factors such inflammation, malnutrition and increased oxidative stress that enhance and accelerate atherosclerosis in addition to traditional risk factors. Although relation between cardiovascular and cerebrovascular diseases with CKD is well established, studies are suggesting about association of Peripheral Arterial Disease (PAD) with CKD. PAD is associated with increased morbidity and mortality in patients of CKD.

This study is rendezvous to look for PAD and related risk factors in patients of CKD having eGFR less than 60 ml/ min/ 1.73 m2 (MDRDS) and not on RRT.

Two hundred ten subjects with CKD attending department of nephrology at tertiary care institute in valley were included in study. Out of 210 subjects selected, 30 were having PAD that constituted 14% of study population. IC was seen in 25 (11.9%) of 210 subjects. Out of PAD patients 16 (53.3%) were having history of IC and 14 (46.7%) were asymptomatic. As reported in literature, prevalence of peripheral arterial disease in CKD patients not on dialysis ranged from 7% to 32% in previous cases. This study will sensitize us to plan more effective screening, preventive and management strategies. This will go long way to decrease morbidity and mortality in patients.

Mohamad Muzzafer Mir*, Mohamad Saleem Najar, Bipin Kumar Sharma, Mangit Singh, Ursilla Taranum Mir and Majid Khalil Rather